Tibetan patients with essential hypertension caused by underlying oxidative metabolism dysfunction and depressed nitric oxide synthesis

Chinese Medical Journal

Volumn 116, Issue 2, 2003, Pages 309-311

  Li, Dangsheng ^a   Wang, Xiongwei ^b   Fu, Zhongming ^b   Yu, Jun ^b   Da, Wenli ^b   Peng, Shunzhou ^b   Wang, Xiangui ^b  

^a Third Department Internal Medicine   (China)

^b 41st Hospital of PLA   (China)

Author keywords

Essential hypertension; Nitric oxide synthesis; Oxidative metabolism; Pathogenesis; Tibetan patient

Indexed keywords

ANTIOXIDANT; MALONALDEHYDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SUPEROXIDE DISMUTASE;

ADULT; AEROBIC METABOLISM; ARTICLE; ASSAY; BIOSYNTHESIS; BLOOD LEVEL; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; METABOLIC DISORDER; PATHOPHYSIOLOGY; VOLUNTEER;

ADULT; ALTITUDE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITRIC OXIDE; OXIDATION-REDUCTION; TIBET;

EID: 0037320720     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cardillo C, Kilcoyne CM, Quyyumi AA, et al. Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilation in patients with essential hypertension. Circulation 1998;97:851-856.
2. Edelman ER. Vessel size, antioxidants, and restenosis. Circulation 1998;97:416-420.
3. Guidelines Subcommitee 1999 World Health Organization - International Society of Hypertension. Guidelines for the management of hypertension. J Hypertens 1999;17:151-183.
4. Zuo BH, Zhou ZY, Yang HJ, et al. Changes in serum malondialdehyde and platelet aggregative function in patients with hypertension. Chin J Hypertens 1996;4:271-273.
5. Shi B, Wang PR, Shi L, et al. Relationship between lipid peroxidation and essential hypertension before and after antihypertensive treatment. Chin Circ J 1995;9:518-520.
6. Jiang GQ, Zhao LY, Li HW, et al. Relationship between nitric oxide and hypertensive scale in patients with essential hypertension. Chin Prac J Heart Cereb Lung Vascul Dis 1998;6: 6-7.
7. Guo ZG, Weng CH, Liu YL, et al. The changes of oxygen free radical, nitric oxide and fibrinolytic activity in plasma of the patients with coronary artery disease and hypertension. Chin Circ J 1996;7:435-437.
8. Zhang XZ, He FW, Kang XW, et al. Changes of RBC-SOD and GHS-PX among the population residing in high altitude and after returned to plate. Chin J Intern Med 1994;4;448-450.
9. Zhang XZ, Cui JH, Chen ZS, et al. The comparative study of free radical metabolism of youths in native Tibetans and migrated Hans at 4300m altitude. J High Altit Med 2000;2:2-11.
10. Fike CD, Kaplowitz MR, Thomas CJ, et al. Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthases in newborn pig lungs. Am J Physiol 1998;274:L517-L526.
11. Mcquillan LP, Leung GK, Marsden PA, et al. Hypoxia inhibits expression of NOS via transcriptional and posttranscriptional mechanisms. Am J Physiol 1994;267:H1921-1927.
12. Toporsian M, Govindaraju K, Nagi M, et al. Downregulation of endothelial nitric oxide synthase in rat aorta after prolonged hypoxia in vivo. Circ Res 2000;86:671-675.
13. Matsushita H, Morishita R, Nata T, et al. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB ( NF-kappaB )-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation. Circ Res 2000;86:974-981.
14. Gonzalez NC, Wood JG. Leukocyte-endothelial interactions in environmental hypoxia. Adv Exp Med Biol 2001;502:39-60.
15. Ali MH, Schlidt SA, Chandel NS, et al. Endothelial permeability and IL-6 production during hypoxia: role of NOS in signal transduction. Am J Physiol 1999;277:L1057-1065.
16. Wood JG, Johnson JS, Mattioli LF, et al. Systemic hypoxia promotes leukocyte-endothelial adherence via reactive oxidant generation. J Appl Physiol 1999;87:1734-1740.